Global Life Science Ventures Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

Dr. Ing. Peter H. Reinisch

Dr. Ing. Peter H. Reinisch, Partner

Dr. Reinisch has over 14 years experience in the life science industry that included senior management positions in the Corange group (Boehringer Mannheim and DePuy) for 11 years. He was responsible for the strategic coordination and business development of the diagnostics business worldwide. From 1994 to 1996 he advised Boehringer Mannheim and Corange, including from 1995 on the setting up of GLS I. He has acted as a board member, or attendee, with a number of portfolio companies, five of which are already public - four by IPO, one by reverse take-over. In addition, another company recently exited through a trade sale. He has been advising GLS I and GLSV II since the beginning in 1996 and is Managing Director of the advisory company based in Zug/Switzerland.

Prior to Corange/Boehringer Mannheim, Dr. Reinisch held positions of increasing responsibility with Brown Boveri, the Institute for Automation, the Denner Group and McKinsey and Co., where he concentrated on high technology industries. He became CEO of Pfister, one of his clients.

Dr. Reinisch, born in 1940, first studied mechanical engineering, then graduated summa cum laude with a doctorate in Business Administration ("Betriebswissenschaften") from the Technical University of Vienna.

< back